Stockholm, Sweden – iZafe Group AB (publ) (NASDAQ First North: IZAFE B) – a leading Life- Science company focused on health care digitalisation, today announces the appointment of Ida Almgren as the new CFO. Ms Almgren will join the company on 9 November 2020.
Ida Almgren has many years of experience with and responsibility for business analysis and financial planning with established companies. Ms Almgren’s professional experience includes working with high-growth companies and start-ups in various phases of development, where her areas of focus included strategy and growth. Immediately prior to joining iZafe, Ms Almgren served in the role of Revenue Manager for SAS, and was previously the CFO of Thunderkick.
“I bring expertise to iZafe Group acquired through my experience as a CFO and member of executive management teams in roles that entailed overall financial responsibility. I look forward to returning to a smaller, entrepreneurial company where I can be involved in internationalising and further developing the business,” says CFO Ida Almgren, iZafe Group.
Contacts
Thomas Ahlerup, IR contact
E-mail: thomas.ahlerup@izafe.se
Phone number: +46 76-896 63 00
iZafe Group AB (publ)
Grev Turegatan 11A
114 46 Stockholm
E-mail: ir@izafe.se
investor.izafe.se
About Us
iZafe Group is a Swedish med-tech company that develops and markets medical and digital security solutions to create safer drug handling at home. Our digital medicine dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. Our products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life.
The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: info@fnca.se. Further information is available at investor.izafe.se.